NSCLC treatment can cost tens of thousands of dollars a month. Most patients don’t realize how many programs exist to cover the bills — from pharmaceutical companies offering free medication to foundations that pay your copays directly. This guide cuts through the confusion and tells you exactly what to do first.
A diagnosis of non-small cell lung cancer brings financial shock alongside everything else. Treatment for advanced cases can exceed $30,000 a month in total healthcare costs, and even with insurance, the gaps are brutal. These are the questions patients and families ask most — answered directly, without filler.
1 Is there actually money available to help pay my NSCLC treatment bills? Yes — foundations, pharmaceutical companies, and government programs each cover a different piece. Apply to all of them, not just one. ▼
2 I’m on Medicare. Does the new drug cost cap apply to my NSCLC medications? Partially — the $2,100 cap covers Part D oral drugs, but Part B infusion drugs (like many chemotherapy and immunotherapy regimens) have a separate cost structure with no annual cap. ▼
3 Can I get SSDI disability benefits with an NSCLC diagnosis? Likely yes, and possibly faster than you’d expect — inoperable or metastatic NSCLC qualifies for the Social Security Compassionate Allowances program, which fast-tracks decisions to as little as 10–19 days. ▼
4 My oncologist prescribed an expensive targeted therapy. Can I get it for free? Often yes — most major NSCLC drug manufacturers run patient assistance programs that provide the medication at no cost for patients below income thresholds, which are typically quite generous (up to $150,000/year for some programs). ▼
5 What is “financial toxicity” and why does it matter for my treatment? Financial toxicity is the real, measurable harm that treatment costs cause to patients’ health outcomes — not just their bank accounts. Research shows that patients who receive financial assistance survive significantly longer than those who don’t. ▼
6 I can’t drive and my treatment center is far away. Is there help with transportation? Yes — the American Cancer Society’s Road to Recovery connects patients with volunteer drivers at no charge. For longer distances, Angel Flight and Corporate Angel Network provide free air travel to treatment centers. ▼
7 What’s the single most important first call I should make after diagnosis? Your hospital’s financial counselor or oncology social worker — before your second appointment if possible. They have access to programs that aren’t publicly advertised and can submit applications on your behalf. ▼
8 A fund I applied to is closed. Now what? Join the waitlist and set a PAN FundFinder alert — then immediately apply to every other open fund. Foundation funds open and close throughout the year, sometimes within hours of an announcement. ▼
These programs pay your copays, deductibles, and premium costs directly — they don’t give you cash, but they eliminate the bills that would otherwise arrive after your insurance processes a claim. Apply to all of them simultaneously. Fund availability changes frequently.
The PAN Foundation provides up to $9,600 per year specifically for non-small cell lung cancer medication costs. In March 2026, PAN and the Patient Advocate Foundation announced a merger — but nothing has changed for patients in the interim. You still apply through panapply.org or by phone. The fund covers medication copays and premiums for NSCLC patients who meet income eligibility requirements. If the fund shows as closed, join the waitlist and set a FundFinder alert — the fund reopens as new contributions arrive. Funds that run out in January sometimes reopen in March or April with new pharmaceutical company contributions.
HealthWell runs two separate NSCLC funds: a general fund with average grants around $6,000, and a Medicare Access fund with average grants around $3,000 specifically structured for Medicare Part B costs. Eligibility requires having some form of health insurance (private, Medicare, Medicaid, or TRICARE) — HealthWell covers the gaps your insurance leaves behind, not the entire bill. Income eligibility extends up to 300–500% of the Federal Poverty Level depending on fund. If you’re on Medicare and paying 20% coinsurance on infusion chemotherapy or immunotherapy, the Medicare Access Fund is specifically designed for your situation. Apply at healthwellfoundation.org.
PAF’s Co-Pay Relief program helps insured NSCLC patients — including those with Medicaid, Medicare, and TRICARE — cover treatment copays and prescription costs when those costs become unmanageable. Eligibility requires being insured, actively in treatment or having a treatment plan, residing and receiving treatment in the United States, and having income at or below 500% of the Federal Poverty Level. PAF also runs a Health Equity Fund for NSCLC using CDC Social Vulnerability Index data — if you live in one of 226 high-vulnerability counties, check whether you qualify for this targeted fund even if the general fund is closed. Apply at copays.org or call 1-866-512-3861.
Good Days is notable for covering categories other funds skip: in addition to copays and premium assistance, the NSCLC fund can cover diagnostic testing costs and travel costs related to treatment. These are often the expenses that fall through every other program’s cracks. Good Days funds open and close throughout the year — if the fund is listed as closed when you check, call them directly, as the status can change within days. The online application takes about 15 minutes. Income and insurance requirements apply; call for current eligibility thresholds. Phone for patient information: 877-968-7233. Apply at mygooddays.org.
The Assistance Fund covers copays, coinsurance, and deductibles for all FDA-approved treatments for non-small cell lung cancer — meaning it follows your specific treatment plan rather than covering only certain drugs. This is an important distinction: if your oncologist has prescribed an FDA-approved targeted therapy or immunotherapy for your NSCLC, TAF covers the patient cost-sharing for it without requiring you to be on a specific drug. TAF also allows retroactive assistance in some circumstances. Find current fund status and apply at theassistancefund.org or call 855-845-3663.
CancerCare’s Co-Payment Assistance Fund provides grants up to $6,000 for NSCLC patients with federal health insurance (Medicaid, Medicare, or TRICARE) who are in active treatment. The fund covers the out-of-pocket costs associated with covered treatments. Importantly, CancerCare will consider retroactive reimbursement for dates of service within 60 days prior to the approval date for first-time applicants — if you’ve already received treatment and paid out of pocket in the past two months, you may recover some of those costs. CancerCare also offers free counseling, support groups, and financial coaching as part of the same organization. Apply at cancercare.org or call 1-800-813-4673.
FundFinder is a free tool from the PAN Foundation that tracks the open or closed status of more than 200 assistance funds across nine major patient assistance charities. Instead of checking each foundation’s website daily, you enter your diagnosis and receive an immediate alert when any relevant fund opens. Since its launch, FundFinder has sent over 500,000 notifications to patients. This is not a grant itself — it’s the alert system that tells you when to apply for grants. Sign up immediately after reading this guide. When a fund opens after being closed for months, thousands of patients apply within hours — being on the waitlist and having your documentation ready gives you a real advantage. Access FundFinder at panfoundation.org.
LUNGevity, the largest lung cancer–focused nonprofit in the United States, operates a Financial Treatment Program in partnership with Family Reach that gives NSCLC patients free one-on-one consultations with a Certified Financial Planner who specializes in cancer-related financial challenges. This is not a cash grant — it’s professional financial navigation that helps you identify every resource available to you, create a realistic budget for treatment, and address secondary financial fallout like housing, debt, and employment. Patients who use this service consistently find programs they had no idea existed. Qualify: any lung cancer patient or caregiver experiencing financial stress. Apply at lungevity.org under Help & Resources → Financial Treatment Program.
The SAMFund specifically serves cancer survivors and patients in their 20s and 30s — an age group that NSCLC increasingly affects, particularly patients with EGFR mutations who have never smoked. The fund provides grants covering both medical costs and daily living expenses including rent, utilities, student loan payments, and transportation that pile up during treatment when income drops. If you were diagnosed with NSCLC before age 40, SAMFund should be one of your first applications. Eligibility requires being in treatment or within five years of completing treatment and being under a certain age threshold (verify current limits at thesamfund.org). Apply at thesamfund.org.
Triage Cancer is a nonprofit that offers free legal and financial education specifically for cancer patients. Their online resources include a financial assistance tool that filters by state and diagnosis, surfacing programs that many national directories miss — including state-specific pharmaceutical assistance, employer-benefit rights during leave, and insurance appeal resources. Triage Cancer is especially useful for understanding your workplace rights during NSCLC treatment — including what FMLA protects, what disability benefits you’re entitled to through your employer, and how to navigate insurance denials. All resources are free at triagecancer.org. They also run free educational webinars open to any cancer patient.
Drug manufacturers are legally required to make their assistance programs available, but they don’t advertise them aggressively. For expensive targeted therapies like osimertinib, erlotinib, or pembrolizumab, the manufacturer program may provide your medication entirely free if you meet income requirements — which are often set far higher than people expect.
AstraZeneca manufactures several drugs used in NSCLC treatment, including osimertinib (Tagrisso), which is a standard treatment for EGFR-mutated NSCLC, and durvalumab (Imfinzi). The AZ&Me program provides these medications free or at reduced cost to patients who are uninsured, underinsured, or whose insurance does not cover the medication. Income thresholds are set to be inclusive rather than restrictive — many patients who consider themselves middle-income qualify. Ask your oncologist’s office whether any of your prescribed medications are AstraZeneca products, then apply through their patient support team or at azandme.com.
Genentech’s patient assistance program covers uninsured patients or patients whose insurance does not cover their prescribed Genentech medication, with a household income threshold of under $150,000 per year — one of the more generous income limits in the industry. Genentech manufactures atezolizumab (Tecentriq), alectinib (Alecensa), and other drugs used in NSCLC depending on biomarker profile. The fact that this threshold is $150,000 surprises most patients — it’s not just for low-income families. Apply at gene.com/patients or through your oncologist’s office, which will have the most direct enrollment pathway for their specific Genentech drugs.
Pembrolizumab (Keytruda) is one of the most commonly prescribed immunotherapy drugs for NSCLC with high PD-L1 expression. Merck’s patient assistance program provides it at no cost to patients who are uninsured or whose insurance does not cover the medication. For patients who are insured but facing high copays for Keytruda infusions, ask your oncologist specifically about the Merck Access Program, which operates separately from the Merck Helps assistance program and is structured for commercially insured patients. Contact Merck’s patient support line at 1-800-727-5400 or ask your infusion center’s billing coordinator, who manages these arrangements regularly.
BMS manufactures nivolumab (Opdivo), which is used in several NSCLC treatment regimens, and relatlimab/nivolumab (Opdualag). The BMS Patient Assistance Foundation provides medications at no charge to patients who are uninsured or underinsured and meet income eligibility criteria. BMS Access Support also operates a separate copay assistance program for commercially insured patients. The fastest way to access either program is through your oncologist’s nurse navigator or the infusion center’s financial counselor, who will know which BMS program applies to your specific insurance situation and can often initiate enrollment in the same appointment. Contact BMS at 1-800-736-0003.
Pfizer manufactures crizotinib (Xalkori) and lorlatinib (Lorbrena) used in ALK-positive NSCLC, among others. The Pfizer RxPathways program connects patients to copay assistance, free medication programs, and insurance support depending on their coverage situation. This matters most for patients with ALK or ROS1 mutations, where these targeted drugs are the standard of care and can cost tens of thousands of dollars per month. Pfizer RxPathways acts as a navigation service — a counselor reviews your insurance situation and routes you to the most applicable program. Call 1-844-989-PATH (7284) or visit pfizerrxpathways.com.
NeedyMeds is a nonprofit that maintains the most comprehensive free database of pharmaceutical patient assistance programs available — covering virtually every manufacturer. Enter your specific NSCLC medication name and your insurance status and it returns every available assistance program, current eligibility requirements, and direct application links. NeedyMeds also provides a free drug discount card that can reduce out-of-pocket costs at participating pharmacies even when no other assistance is available — it requires no enrollment and no income verification, and it’s accepted at most chain and independent pharmacies nationwide. Visit needymeds.org or call 1-800-503-6897 for the helpline.
The Medicine Assistance Tool is maintained by PhRMA, the pharmaceutical industry association, and covers all member company patient assistance programs in a single searchable database. Enter your medication name and insurance status to see every manufacturer program that applies to your situation, including programs for patients with insurance who still face high costs. MAT is useful because it covers medications that NeedyMeds may not have updated yet, particularly newly approved NSCLC drugs. If your targeted therapy was approved within the last 12 months, MAT and your oncologist’s nurse navigator are the best sources for current program information. Visit medicineassistancetool.org.
Boehringer Ingelheim manufactures afatinib (Gilotrif), used in EGFR-mutated NSCLC. The BI Cares Foundation Patient Assistance Program provides medications at no charge to patients who cannot afford them, including seniors and families on limited incomes. Two separate phone lines handle different medications to route you correctly. If your oncologist has prescribed Gilotrif and you’re struggling with the cost, call the dedicated line for that drug rather than the general line — it connects you directly to the program team handling that medication’s assistance fund. General line: 1-800-556-8317. Gilotrif-specific line: 1-855-297-5904.
Federal and state programs form the foundation of coverage for most NSCLC patients. The details matter — the Medicare drug cost cap, how SSDI Compassionate Allowances work for lung cancer, and what Medicaid covers vary in ways that directly affect your treatment decisions.
Medicare is the primary insurer for most NSCLC patients over 65. Medicare Part B covers intravenous chemotherapy and immunotherapy administered in a clinical setting — and pays 80%, leaving patients responsible for 20% with no annual cap unless they have supplemental coverage. Medicare Part D covers oral cancer drugs — and now carries a $2,100 annual out-of-pocket cap for this calendar year, after which covered Part D drugs cost you nothing for the rest of the year. If you’re on a daily oral targeted therapy like osimertinib, you will hit the Part D cap before mid-year in most cases, which dramatically changes the economics of your treatment. Medicare Extra Help (Low Income Subsidy) can reduce your Part D costs to a few dollars per prescription if your income and resources meet eligibility — apply at ssa.gov or call Medicare at 1-800-633-4227.
Medicare Extra Help is the most valuable program most Medicare beneficiaries with limited income never apply for. If you qualify, it caps your Part D drug copays at a very low fixed amount — currently in the range of a few dollars per prescription — regardless of how expensive your NSCLC medication actually is. For NSCLC patients on expensive oral targeted therapies, qualifying for Extra Help can mean the difference between $500 per month and less than $15 per month for the same drug. Many people who qualify don’t know they qualify. Automatic qualification applies if you receive Medicaid, Supplemental Security Income, or Medicare Savings Program assistance. Everyone else can apply through the Social Security Administration at ssa.gov/medicare/part-d-extra-help or by calling 1-800-772-1213.
Medicaid is the most comprehensive coverage available for NSCLC treatment — it typically covers surgery, chemotherapy, radiation, immunotherapy, and oral targeted drugs with minimal or no copays for patients who qualify. More than 71 million Americans have Medicaid, and eligibility has expanded significantly in states that accepted the ACA Medicaid expansion. Even if you’ve been denied before, reapply — your eligibility changes if your income has dropped due to inability to work during treatment. Approval for a severe medical condition can sometimes be immediate at healthcare.gov. Because each state runs its own Medicaid program, income limits vary — contact your State Health Department or apply at healthcare.gov to see current thresholds.
Inoperable, unresectable, or recurrent NSCLC — and any NSCLC with spread to or beyond the hilar lymph nodes — qualifies for the Social Security Administration’s Compassionate Allowances program, which expedites disability claim reviews to an average of 19 days. The standard SSDI five-month waiting period before payments begin still applies, but the initial determination happens quickly. File the day you can no longer work — the waiting period starts from that date, not from when your claim is approved. Monthly SSDI payments are based on your earnings history. After 24 months of SSDI, you automatically receive Medicare. Apply online at ssa.gov/disabilityssi or call 1-800-772-1213. Bring your diagnosis documentation, treatment plan, and work history to the application.
SSI is a separate Social Security program from SSDI — it doesn’t require a work history to qualify, which matters for patients who haven’t accumulated enough Social Security credits through employment. SSI is needs-based: it provides monthly cash payments to people who are disabled (including with NSCLC) and have limited income and resources. Receiving SSI also automatically qualifies you for Medicaid in most states and for Medicare Extra Help — which dramatically affects your treatment costs. Many NSCLC patients qualify for both SSDI and SSI, or for SSI alone if they haven’t worked enough years to qualify for SSDI. Apply at the same SSA number or website as SSDI — the application covers both programs.
For NSCLC patients under 65 who are uninsured or whose employer coverage has lapsed, the ACA Health Insurance Marketplace provides subsidized coverage. Losing a job or reducing to part-time work due to your diagnosis counts as a qualifying life event, triggering a Special Enrollment Period — you don’t have to wait for open enrollment. Subsidies based on income can dramatically reduce monthly premiums, and the Enhanced Premium Tax Credits that were extended through 2025 remain available. Even a marketplace plan with a high deductible may be worth enrolling in immediately — it gives manufacturer copay cards and foundation grants a secondary payer to work against, which is required by many of those programs. Apply at healthcare.gov or call 1-800-318-2596.
Every nonprofit hospital in the United States — and that’s the vast majority of cancer centers — is required by the IRS to have a financial assistance (charity care) program as a condition of their tax-exempt status. These programs are not well advertised but they are legally mandated. For NSCLC patients facing large hospital bills for surgery, inpatient stays, or infusion treatment, this program can reduce or eliminate what you owe. Ask specifically for the Financial Assistance Program, not just a payment plan — the wording matters. Bring proof of income, your insurance information, and your diagnosis. If you’ve already received care and received a bill, you can apply retroactively — many hospitals accept applications up to 240 days after the service date.
NSCLC often requires treatment at specialized cancer centers — which means travel. For patients near major academic medical centers, this is manageable. For those in rural areas or smaller cities, the cost of getting to and from treatment is a significant and often overlooked financial burden that dedicated programs exist to address.
Hope Lodge provides free overnight accommodations for cancer patients and their caregivers when treatment requires travel away from home. There are 31 Hope Lodge facilities across the United States, each located near a major cancer treatment center. To qualify, you must be receiving active cancer treatment and live more than 40 miles or one hour from your treatment center. Every guest must be accompanied by a caregiver during their stay — this is a firm policy, not a guideline. Services are provided entirely free of charge regardless of income, funded by donations. The American Cancer Society also operates an Extended Stay America partnership for cities where Hope Lodge facilities don’t exist. Contact ACS at 1-800-227-2345 or cancer.org to find the nearest location and check availability.
Road to Recovery matches cancer patients with volunteer drivers in their local community for free rides to and from cancer treatment appointments. This is particularly valuable for NSCLC patients who can no longer drive due to fatigue, medication side effects, or post-surgical recovery. The program relies on local volunteer availability, so coverage varies by area — call well in advance of your appointments to confirm a driver is available in your community. ACS also provides transportation grants to healthcare system partners who run their own transport programs. Call 1-800-227-2345 and ask specifically about Road to Recovery in your area.
For NSCLC patients who need to travel to specialized cancer centers for biomarker testing, clinical trial enrollment, or treatment not available locally, two organizations provide free air transportation. Angel Flight America uses a network of volunteer pilots flying private aircraft on shorter-distance routes across their regional coverage areas. Corporate Angel Network arranges free flights on corporate jets for cancer patients traveling to recognized treatment centers. Both require some advance planning — these are not last-minute resources, and eligibility requires being ambulatory (able to walk on and off the aircraft without assistance). Ask your oncologist’s social work team which organization covers your specific route. Angel Flight: angelflightamerica.org. Corporate Angel: corpangelnetwork.org.
Financial assistance doesn’t cover everything a diagnosis costs. Professional counseling, legal help, insurance appeals, and peer support are all available at no charge — and they address the parts of treatment no grant can cover.
CancerCare provides free professional counseling with licensed oncology social workers — by phone, online, or in person in some locations — to any cancer patient or family member, regardless of income or insurance status. This is not peer support: these are trained clinical social workers who specialize in the emotional and practical challenges of cancer. CancerCare also runs free support groups specific to lung cancer, educational workshops, and financial coaching sessions. The financial coaching service helps patients identify the specific programs they qualify for and navigate applications — it overlaps with the co-payment fund but extends further into practical assistance. Call 1-800-813-4673 or visit cancercare.org. Counseling is available in Spanish as well.
The American Lung Association operates a Lung HelpLine staffed by nurses and respiratory health educators who can answer questions about NSCLC treatment, navigate insurance challenges, and connect callers to specific financial assistance programs. The HelpLine is free and available to anyone, not just ALA members. The ALA also maintains a financial assistance resource page that includes state-by-state program listings for pharmaceutical assistance, patient navigation services, and the Patient Advocate Foundation’s TotalAssist program — which provides financial assistance for over 130 diseases including lung cancer. If you’re unsure where to start, the Lung HelpLine is a good first call — they can point you to the programs most relevant to your specific state, insurance situation, and diagnosis. Call 1-800-548-8252 or visit lung.org.
The first call to make is to your hospital’s oncology financial counseling department — ask before your second appointment. They will review your insurance, identify gaps, and submit applications to copay foundations on your behalf. At the same time, call the American Lung Association HelpLine at 1-800-548-8252 and ask what’s open for NSCLC patients right now. Sign up for PAN FundFinder at panfoundation.org immediately so you receive alerts when funds open. If you have Medicare, confirm with your billing team which of your treatments fall under Part B versus Part D — the distinction determines where your costs come from and which foundation programs apply. Apply to PAN Foundation, HealthWell, Good Days, Patient Advocate Foundation, and CancerCare all in the same week — they cover different costs and different insurer types. Apply for SSDI or SSI at ssa.gov if you can no longer work.
You have two immediate avenues. First: apply for Medicare Extra Help (Low Income Subsidy) at ssa.gov — if your income and savings are below the threshold, this can reduce Part D drug copays to a few dollars per prescription. Second: apply to HealthWell Foundation’s Medicare Access Fund, which is specifically designed to cover the 20% coinsurance Medicare Part B leaves behind on infused chemotherapy and immunotherapy. Good Days also covers NSCLC-related premium, copay, diagnostic, and transportation costs for Medicare patients. If your out-of-pocket costs for Part D drugs have already hit $2,100 this calendar year, stop paying immediately — your plan covers 100% from that point forward. Call Medicare at 1-800-633-4227 if your plan is still billing you after you’ve hit the cap.
Your first call is to the drug manufacturer’s patient assistance line — ask your oncologist’s nurse navigator which company makes your medication, then search that company’s program through rxassist.org or needymeds.org. Income thresholds are often far higher than patients expect: Genentech’s program extends to households under $150,000 per year. While you’re pursuing that, also apply to PAN Foundation and The Assistance Fund, both of which cover FDA-approved NSCLC targeted therapies. If your insurance covers the drug but at a high copay, you need a copay foundation; if your insurance doesn’t cover it at all, you need the manufacturer program — these are different things and you may need both. Your oncologist’s billing team handles these requests regularly and can often enroll you in the right program during a single phone conversation.
Start with three simultaneous steps. First: apply for Medicare Extra Help — many seniors who qualify have never applied. Second: call the LUNGevity Financial Treatment Program to get a free consultation with a Certified Financial Planner who understands cancer costs specifically. Third: ask your oncologist’s social worker about the hospital’s own financial assistance program — nonprofit hospitals are federally required to have one, and it can reduce or eliminate the portion insurance doesn’t cover. If you receive Meals on Wheels, ask your coordinator whether your local chapter has expanded services for medical appointments — many chapters now help with coordination and transportation as well as food. The Eldercare Locator at 1-800-677-1116 can also connect you to local programs not findable through standard searches.
Contact your oncology team’s social work department before your first visit and specifically ask about travel assistance. The American Cancer Society Hope Lodge — free housing near cancer centers for patients who travel more than 40 miles — should be your first check. The nearest Hope Lodge location and current availability are at cancer.org or by calling 1-800-227-2345. For air travel, ask the social work team about Angel Flight America and Corporate Angel Network — both require advance planning and are not last-minute options. Good Days covers NSCLC-related travel costs as part of its disease fund, which is unusual among the foundations. The combination of Hope Lodge for lodging and Road to Recovery for local transportation to appointments eliminates much of the daily cost of treatment travel for patients who plan ahead.
A denial is not a final answer — it’s a starting point for an appeal. Your oncologist’s office handles insurance appeals regularly and may initiate one on your behalf; ask directly whether they will write a letter of medical necessity. Triage Cancer at triagecancer.org offers free resources and webinars on navigating insurance denials for cancer patients, including scripts for appeals and information on your legal rights. Many states require insurance companies to use external review when appeals are denied — Triage Cancer’s state-by-state resources explain how to request an external review in your state. CancerCare’s social work team also helps patients navigate insurance denials at no charge — call 1-800-813-4673. If the insurance denial involves Medicare, contact your State Health Insurance Assistance Program (SHIP) for free independent guidance.
This is not optional and it is not a sign of need — it is the standard of care at every accredited cancer center. Ask your oncologist’s office at your first visit to schedule a financial counseling appointment or social work consultation before your next one. That person will review your specific insurance coverage, identify every gap, match you to foundation programs based on your insurer and income, and often submit applications on your behalf. Many patients who do this early in treatment discover thousands of dollars in assistance they would never have found alone. If your center hasn’t mentioned this service, call the main number and ask for “oncology financial counseling” or “oncology social work.”
Go to panfoundation.org and sign up for FundFinder alerts for non-small cell lung cancer. This takes five minutes and ensures you receive notification the moment any of the 200+ tracked funds opens. In the same session, check the current status of the PAN Foundation NSCLC fund, HealthWell Foundation, Good Days, Patient Advocate Foundation Co-Pay Relief, CancerCare, and The Assistance Fund — all of these have NSCLC-specific programs with different open/close cycles. Apply to every one that is currently open. Do not apply to one and wait — apply to all of them in a single sitting, ideally in the first week after diagnosis.
Every medication your oncologist prescribes has a manufacturer, and every major NSCLC drug manufacturer has a patient assistance program. Write down the name of every drug you’ve been prescribed — including supportive medications — and ask your nurse navigator or the billing coordinator which manufacturer makes each one and whether their assistance program applies to your coverage situation. This conversation takes less than ten minutes and can result in free medication that would otherwise cost you thousands of dollars per month. The RxAssist directory and the PhRMA Medicine Assistance Tool are also available at rxassist.org and medicineassistancetool.org for self-guided research.
- Your diagnosis documentation in writing — a letter from your oncologist or pathology report stating your NSCLC diagnosis, subtype if known, and stage. Most foundation programs require a physician signature.
- Your current insurance card and a recent Explanation of Benefits (EOB) — foundations need to know what your insurance covers and what your cost-sharing looks like before they can determine what they can cover.
- Proof of income — a recent tax return, pay stub, or Social Security award letter. If your income has dropped since diagnosis, a current bank statement showing reduced earnings is often acceptable.
- Your treatment plan or prescription — most drug-specific programs require documentation that the medication was prescribed for your specific diagnosis by a licensed oncologist.
- Your oncologist’s billing contact — most programs pay providers directly and need a point of contact at your treatment center. Get the billing department’s name and fax number before leaving your appointment.
- Your Social Security number — required for most programs to verify you are a U.S. resident receiving treatment in the United States.
This guide is independent and is not affiliated with, sponsored by, or endorsed by any program, foundation, or pharmaceutical company listed. Program eligibility, grant amounts, fund availability, income thresholds, and contact information change frequently — always verify directly with each organization before applying. Some programs open and close multiple times per year. Medicare caps, income thresholds, and government program rules are subject to change. This content is entirely original and does not reproduce material from any external source.